Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative-Reference-Cited by-同舟云学术

Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative

Published:2016-03-29 Issue:2 Volume:18 Page:210-215
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Beaird O.E.¹,Freifeld A.²,Ison M.G.³^ORCID,Lawrence S.J.⁴,Theodoropoulos N.⁵,Clark N.M.⁶,Razonable R.R.⁷,Alangaden G.⁸,Miller R.⁹,Smith J.¹⁰,Young J.A.H.¹¹,Hawkinson D.¹²,Pursell K.¹³,Kaul D.R.¹

Affiliation:

1. Department of Internal Medicine; University of Michigan; Ann Arbor Michigan USA

2. Department of Internal Medicine; University of Nebraska; Omaha Nebraska USA

3. Department of Internal Medicine; Northwestern University; Chicago Illinois USA

4. Department of Internal Medicine; Washington University; St. Louis Missouri USA

5. Department of Internal Medicine; The Ohio State University; Columbus Ohio USA

6. Department of Internal Medicine; Loyola University Medical Center; Maywood Illinois USA

7. Department of Internal Medicine; Mayo Clinic; Rochester Minnesota USA

8. Department of Internal Medicine; Henry Ford Health System; Detroit Michigan USA

9. Department of Internal Medicine; University of Iowa; Iowa City Iowa USA

10. Department of Internal Medicine; University of Wisconsin; Madison Wisconsin USA

11. Department of Internal Medicine; University of Minnesota; Minneapolis Minnesota USA

12. Department of Internal Medicine; University of Kansas Medical Center; Kansas City Kansas USA

13. Department of Internal Medicine; University of Chicago; Chicago Illinois USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12510/fullpdf

Reference21 articles.

1. Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease;Kim;J Infect Dis,2014

2. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes;Waghmare;Clin Infect Dis,2013

3. Management of respiratory viral infections in hematopoietic cell transplant recipients;Shah;Am J Blood Res,2012

4. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation;Li;J Heart Lung Transplant,2012

5. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant;Kumar;Am J Transplant,2005

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date;Pediatric Drugs;2023-11-30

2. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication;Antiviral Research;2023-11

3. Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis;Clinical Microbiology and Infection;2023-10

4. Respiratory viral infections including COVID-19 in solid organ transplantation;Current Opinion in Organ Transplantation;2023-09-26

5. A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant;The Journal of Heart and Lung Transplantation;2023-07